Study Conduct

Quintiles selects BRANY as U.S. Prime site

Monday, April 22, 2013 11:48 AM

BRANY (Biomedical Research Alliance of New York) has been designated a Quintiles Prime Site. The designation will advance BRANY’s participation in clinical trials by providing improved access to new industry-sponsored clinical trials.

More... »

IOM to develop consensus study on strategies for sharing clinical trial data

Wednesday, April 10, 2013 09:46 AM

The Institute Of Medicine (IOM) plans to follow up on its recent workshop, Sharing Clinical Research Data, by developing a consensus study on strategies for sharing clinical trial data.

More... »

InDex Pharma completes patient recruitment in phase III ulcerative colitis study with Kappaproct

Monday, April 8, 2013 10:07 AM

InDex Pharmaceuticals, a Swedish biopharmaceutical company, has completed patient enrollment for its phase III COLLECT study of Kappaproct. The multinational, randomized, double-blind, placebo-controlled study reached the recruitment goal of 120 patients with treatment-refractory ulcerative colitis (UC). InDex is expecting final study results in mid-2014.

More... »

ActiGraph releases API supporting actigraphy data collection

Monday, April 8, 2013 08:00 AM

ActiGraph, a provider of objective physical activity and sleep/wake monitoring solutions, has released an Application Programming Interface (API) to its popular ActiLife analysis software.

More... »

William Kennedy of Genentech addresses core operational issues in pediatric trials

Wednesday, April 3, 2013 10:47 AM

Increased pressure to conduct trials in children can be daunting when faced with practical, legal and clinical considerations found only in pediatric trials. Successfully implementing regulations and ethical standards into study conduct requires a comprehensive understanding of the unique concerns raised by ethics committees, investigators and parents.

More... »

ACRP and IISRA to merge

Friday, March 29, 2013 03:39 PM

The Association of Clinical Research Professionals (ACRP) and the Investigator Initiated Sponsored Research Association (IISRA) have merged.

More... »

NextDocs, Microsoft mobilize clinical trials with Trial Exchange and Windows 8

Monday, March 25, 2013 11:32 AM

NextDocs, a provider of compliance solutions for the life sciences industry, has launched its new Trial Exchange solution which provides an easy-to-use interface for investigators and site staff to access and contribute essential documents for clinical trials. 

More... »

Benitec selects Duke Clinical Research Unit as a site for HCV phase I/II trial

Monday, March 25, 2013 11:03 AM

RNAi-based therapeutics company Benitec Biopharma has selected the Duke Clinical Research Unit, the early phase unit of the Duke Clinical Research Institute (DCRI) of Durham, N.C., as a site for its upcoming phase I/II first-in-man trial for TT-034 in hepatitis C (HCV). TT-034 is being developed as a potential "one-shot-cure" for HCV.

More... »

Icon launches new Icon Signature Series to share expertise in clinical development

Friday, March 22, 2013 03:04 PM

Icon,a global provider of outsourced development services, has launched the Icon Signature Series, a new thought leadership program that offers expert insight into value-driven strategies for clinical development. 

More... »

Almac to host clinical trial workshop series

Wednesday, March 20, 2013 11:06 AM

The Almac Group is hosting its third international series of complimentary workshops this spring, titled “Protocol to Patient: Managing Clinical Supplies in an Evolving Marketplace.”

More... »